VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_20-vv-00186
Package ID: USCOURTS-cofc-1_20-vv-00186
Petitioner: Marylou LaLonde
Filed: 2020-02-21
Decided: 2021-12-17
Vaccine: Tdap
Vaccination date: 2018-05-31
Condition: shoulder injury related to vaccine administration (SIRVA)
Outcome: compensated
Award amount USD: 95000

AI-assisted case summary:
Marylou LaLonde filed a petition for compensation on February 21, 2020, alleging she suffered a shoulder injury related to vaccine administration (SIRVA) after receiving a tetanus, diphtheria, acellular pertussis (Tdap) vaccine on May 31, 2018. The case was assigned to the Special Processing Unit. The respondent filed a Rule 4(c) report conceding that Petitioner's claim met the Table criteria for SIRVA and that she was entitled to compensation. On July 12, 2021, Chief Special Master Brian H. Corcoran issued a ruling on entitlement, finding Petitioner entitled to compensation. Subsequently, on November 15, 2021, Respondent filed a proffer recommending an award of $95,000.00 for pain and suffering, which Petitioner agreed to. On December 17, 2021, Chief Special Master Brian H. Corcoran issued a decision awarding Petitioner a lump sum payment of $95,000.00 for pain and suffering. Petitioner was represented by Ronald Craig Homer of Conway, Homer, P.C., and Respondent was represented by Christine Mary Becer of the U.S. Department of Justice.

Theory of causation field:
Petitioner Marylou LaLonde received a Tdap vaccine on May 31, 2018. She alleged a shoulder injury related to vaccine administration (SIRVA). The Respondent conceded that Petitioner's claim met the Table criteria for SIRVA. The public decision does not describe the specific mechanism of injury, expert testimony, or detailed clinical facts. On July 12, 2021, Chief Special Master Brian H. Corcoran issued a ruling on entitlement finding Petitioner entitled to compensation. On November 15, 2021, Respondent filed a proffer recommending an award of $95,000.00 for pain and suffering, which Petitioner agreed to. On December 17, 2021, Chief Special Master Brian H. Corcoran issued a decision awarding Petitioner a lump sum payment of $95,000.00 for pain and suffering. Petitioner was represented by Ronald Craig Homer, and Respondent was represented by Christine Mary Becer.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_20-vv-00186-0
Date issued/filed: 2021-08-13
Pages: 2
Docket text: PUBLIC ORDER/RULING (Originally filed: 07/12/2021) regarding 31 Ruling on Entitlement Signed by Chief Special Master Brian H. Corcoran. (sw) Service on parties made.
--------------------------------------------------------------------------------
Case 1:20-vv-00186-UNJ Document 34 Filed 08/13/21 Page 1 of 2
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 20-0186V
UNPUBLISHED
MARYLOU LALONDE, Chief Special Master Corcoran
Petitioner, Filed: July 12, 2021
v.
Special Processing Unit (SPU);
SECRETARY OF HEALTH AND Ruling on Entitlement; Concession;
HUMAN SERVICES, Table Injury; Tetanus Diphtheria
acellular Pertussis (Tdap) Vaccine;
Respondent. Shoulder Injury Related to Vaccine
Administration (SIRVA)
Ronald Craig Homer, Conway, Homer, P.C., Boston, MA, for Petitioner.
Christine Mary Becer, U.S. Department of Justice, Washington, DC, for Respondent.
RULING ON ENTITLEMENT1
On February 21, 2020, Marylou LaLonde filed a petition for compensation under
the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the
“Vaccine Act”). Petitioner alleges that she suffered a shoulder injury related to vaccine
administration (“SIRVA”) after receiving the tetanus, diphtheria, acellular pertussis
(“Tdap”) vaccine on May 31, 2018. Petition at 1, ¶ 2. Petitioner further alleges that she
received the vaccine in the United States, that she suffered the effects of her SIRVA for
more than six months, and that neither she nor any other person has filed a civil action or
received compensation for her SIRVA. Id. at ¶¶ 16-18. The case was assigned to the
Special Processing Unit of the Office of Special Masters.
1 Because this unpublished ruling contains a reasoned explanation for the action in this case, I am required
to post it on the United States Court of Federal Claims' website in accordance with the E-Government Act
of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government
Services). This means the ruling will be available to anyone with access to the internet. In accordance
with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information,
the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that
the identified material fits within this definition, I will redact such material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease
of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa
(2012).

Case 1:20-vv-00186-UNJ Document 34 Filed 08/13/21 Page 2 of 2
On July 12, 2021, Respondent filed his Rule 4(c) report in which he concedes that
Petitioner is entitled to compensation in this case. Respondent’s Rule 4(c) Report at 1.
Specifically, Respondent “has . . . concluded that [P]etitioner’s claim meets the Table
criteria for SIRVA.” Id. at 3. Respondent further agrees that Petitioner has satisfied the
statutory and jurisdictional requirements for compensation under the Act. Id. at 4.
In view of Respondent’s position and the evidence of record, I find that
Petitioner is entitled to compensation.
IT IS SO ORDERED.
s/Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
2

================================================================================
DOCUMENT 2: USCOURTS-cofc-1_20-vv-00186-1
Date issued/filed: 2021-12-17
Pages: 5
Docket text: PUBLIC DECISION (Originally filed: 11/16/2021) regarding 38 DECISION Stipulation/Proffer Signed by Chief Special Master Brian H. Corcoran. (sw) Service on parties made.
--------------------------------------------------------------------------------
Case 1:20-vv-00186-UNJ Document 42 Filed 12/17/21 Page 1 of 5
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 20-0186V
UNPUBLISHED
MARYLOU LALONDE, Chief Special Master Corcoran
Petitioner, Filed: November 16, 2021
v.
Special Processing Unit (SPU);
SECRETARY OF HEALTH AND Damages Decision Based on Proffer;
HUMAN SERVICES, Tetanus Diphtheria acellular
Pertussis (Tdap) Vaccine; Shoulder
Respondent. Injury Related to Vaccine
Administration (SIRVA)
Ronald Craig Homer, Conway, Homer, P.C., Boston, MA, for Petitioner.
Christine Mary Becer, U.S. Department of Justice, Washington, DC, for Respondent.
DECISION AWARDING DAMAGES1
On February 21, 2020, Marylou LaLonde filed a petition for compensation under
the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the
“Vaccine Act”). Petitioner alleges that she suffered a shoulder injury related to vaccine
administration (“SIRVA”) after receiving the tetanus, diphtheria, acellular pertussis
(“Tdap”) vaccine on May 31, 2018. Petition at 1, ¶ 2. The case was assigned to the Special
Processing Unit of the Office of Special Masters.
On July 12, 2021, a ruling on entitlement was issued, finding Petitioner entitled to
compensation for her SIRVA. On November 15, 2021, Respondent filed a proffer on
award of compensation (“Proffer”) indicating Petitioner should be awarded $95,000.00,
representing compensation for her pain and suffering. Proffer at 1. In the Proffer,
1 Because this unpublished Decision contains a reasoned explanation for the action in this case, I am
required to post it on the United States Court of Federal Claims' website in accordance with the E-
Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic
Government Services). This means the Decision will be available to anyone with access to the
internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact
medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy.
If, upon review, I agree that the identified material fits within this definition, I will redact such material from
public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease
of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa
(2012).

Case 1:20-vv-00186-UNJ Document 42 Filed 12/17/21 Page 2 of 5
Respondent represented that Petitioner agrees with the proffered award. Id. Based on
the record as a whole, I find that Petitioner is entitled to an award as stated in the Proffer.
Pursuant to the terms stated in the attached Proffer, I award Petitioner a lump
sum payment of $95,000.00, representing compensation for her pain and suffering
in the form of a check payable to Petitioner. This amount represents compensation for
all damages that would be available under Section 15(a).
The clerk of the court is directed to enter judgment in accordance with this
decision.3
IT IS SO ORDERED.
s/Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
renouncing the right to seek review.
2

Case 1:20-vv-00186-UNJ Document 42 Filed 12/17/21 Page 3 of 5
IN THE UNITED STATES COURT OF FEDERAL CLAIMS
OFFICE OF SPECIAL MASTERS
____________________________________
)
MARYLOU LALONDE, )
)
Petitioner, )
) No. 20-186V
v. ) Chief Special Master Corcoran
) ECF
SECRETARY OF HEALTH AND )
HUMAN SERVICES, )
)
Respondent. )
____________________________________)
RESPONDENT’S PROFFER ON AWARD OF COMPENSATION
I. Procedural History
On July 12, 2021, respondent filed a Vaccine Rule 4(c) report concluding that petitioner
sustained the onset of a left shoulder injury related to vaccine administration (“SIRVA”) within
the Table time period following a tetanus-diphtheria-acellular pertussis (“Tdap”) vaccine, and
therefore sustained an injury that is compensable under the terms of the National Childhood
Vaccine Injury Act of 1986, as amended, 42 U.S.C. §§300aa-10 to -34. ECF No. 30.
Accordingly, on July 12, 2021, the Chief Special Master issued a Ruling on Entitlement, finding
that petitioner was entitled to vaccine compensation for SIRVA following the Tdap vaccine she
received on May 31, 2018. ECF No. 31.
II. Items of Compensation
Respondent proffers that petitioner should be awarded $95,000.00 for pain and suffering.
This represents all elements of compensation to which petitioner is entitled under 42
U.S.C. § 300aa-15(a). Petitioner agrees.

Case 1:20-vv-00186-UNJ Document 42 Filed 12/17/21 Page 4 of 5
III. Form of the Award
Petitioner is a competent adult. Evidence of guardianship is not required in this case.
Respondent recommends that the compensation provided to petitioner should be made through a
lump sum payment as described below and requests that the Chief Special Master’s decision and
the Court’s judgment award the following1: a lump sum payment of $95,000.00, in the form of a
check payable to petitioner.
IV. Summary of Recommended Payments Following Judgment
Lump sum payable to petitioner, Marylou LaLonde: $95,000.00
Respectfully submitted,
BRIAN M. BOYNTON
Acting Assistant Attorney General
C. SALVATORE D’ALESSIO
Acting Director
Torts Branch, Civil Division
HEATHER L. PEARLMAN
Deputy Director
Torts Branch, Civil Division
TRACI R. PATTON
Assistant Director
Torts Branch, Civil Division
1 Should petitioner die prior to entry of judgment, the parties reserve the right to move the Court
for appropriate relief. In particular, respondent would oppose any award for future pain and
suffering.
2

Case 1:20-vv-00186-UNJ Document 42 Filed 12/17/21 Page 5 of 5
s/Christine Mary Becer
CHRISTINE MARY BECER
Trial Attorney
Torts Branch, Civil Division
U.S. Department of Justice
P.O. Box 146
Benjamin Franklin Station
Washington, D.C. 20044-0146
Tel: (202) 616-3665
Christine.m.becer@usdoj.gov
DATED: November 15, 2021
3